MEDevice Silicon Valley Brings Together Leading MedTech Suppliers and Experts to Shape the Future of Medical Device Innovation
| 67401PAC2 | 86.04 8.17 8.67% |
About 62% of 67401PAC2's investor base is looking to short. The analysis of the overall prospects from investing in OCSL 27 15 JAN 27 suggests that many traders are, at the present time, alarmed. The current market sentiment, together with 67401PAC2's historical and current headlines, can help investors time the market. In addition, many technical investors use OCSL 27 15 bond news signals to limit their universe of possible portfolio assets.
67401PAC2 |
SANTA CLARA, CA ACCESSWIRE November 14, 2024 MEDevice Silicon Valley, the premier West Coast event connecting medical device engineers and cutting-edge MedTech companies, shares important infor
Read at accesswire.com
 |
OCSL 27 15 Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 67401PAC2 bond to make a market-neutral strategy. Peer analysis of 67401PAC2 could also be used in its relative valuation, which is a method of valuing 67401PAC2 by comparing valuation metrics with similar companies.
Peers
67401PAC2 Related Equities
| 00108WAF7 | 00108WAF7 | 8.10 | ||||
| FTNT | Fortinet | 0.28 | ||||
| PG | Procter Gamble | 0.25 | ||||
| WMT | Walmart | 0.15 | ||||
| INTC | Intel | 0.50 | ||||
| JXN-PA | Jackson Financial | 0.62 | ||||
| CAT | Caterpillar | 0.89 | ||||
| MET | MetLife | 1.53 | ||||
| 90331HPL1 | 90331HPL1 | 2.13 | ||||
| BREA | Brera Holdings | 2.35 |
Other Information on Investing in 67401PAC2 Bond
67401PAC2 financial ratios help investors to determine whether 67401PAC2 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 67401PAC2 with respect to the benefits of owning 67401PAC2 security.